Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
1:27 pm
Purchase
13GRezolute, Inc.
RZLT
CAXTON CORP1,860,518
4.99%
527,045increase
(+39.52%)
View
2023-02-14
12:47 pm
Sale
13GCardiff Oncology, Inc.
CRDF
CAXTON CORP983,607
2.2%
-2,495,733decrease
(-71.73%)
View
2023-02-14
12:30 pm
Sale
13GAddex Therapeutics Ltd
ADXN
CAXTON CORP718,849
0.9%
-1,595,640decrease
(-68.94%)
View
2023-02-14
12:15 pm
Sale
13GXeris Biopharma Holdings, Inc.
XERS
CAXTON CORP5,973,324
4.4%
-1,856,358decrease
(-23.71%)
View
2022-02-14
4:13 pm
Purchase
13GCardiff Oncology, Inc.
CRDF
CAXTON CORP3,479,340
8.1%
380,893increase
(+12.29%)
View
2022-02-14
4:10 pm
Purchase
13GSCYNEXIS, Inc.
SCYX
CAXTON CORP2,210,672
9%
736,302increase
(+49.94%)
View
2022-02-14
4:07 pm
Sale
13GAddex Therapeutics Ltd
ADXN
CAXTON CORP2,314,489
6%
-1,804decrease
(-0.08%)
View
2022-02-14
4:04 pm
Purchase
13GRezolute, Inc.
RZLT
CAXTON CORP1,333,473
8.6%
769,230increase
(+136.33%)
View
2022-02-14
4:01 pm
Sale
13GCTI BioPharma Corp.
CTIC
CAXTON CORP2,239,300
2.3%
-1,510,590decrease
(-40.28%)
View
2022-02-14
3:57 pm
Sale
13GSierra Oncology, Inc.
SRRA
CAXTON CORP1,119,322
7%
-23,039decrease
(-2.02%)
View
2022-02-14
3:52 pm
Unchanged
13GSavara Inc.
SVRA
CAXTON CORP6,896,551
6.1%
0
(Unchanged)
View
2022-01-05
12:50 pm
Sale
13DStrongbridge Biopharma plc
SBBP
CAXTON CORP0
0%
-10,280,682decrease
(Position Closed)
View
2022-01-05
12:38 pm
Purchase
13GXeris Biopharma Holdings, Inc.
XERS
CAXTON CORP7,829,682
5.7%
7,829,682increase
(New Position)
View
2021-03-19
4:53 pm
Purchase
13GSavara Inc.
SVRA
CAXTON CORP6,896,551
6.2%
6,896,551increase
(New Position)
View
2021-02-16
4:39 pm
Purchase
13GSierra Oncology, Inc.
SRRA
CAXTON CORP1,142,361
9.9%
60,161increase
(+5.56%)
View
2021-02-16
4:23 pm
Sale
13GCTI BioPharma Corp.
CTIC
CAXTON CORP3,749,890
5.1%
-737,427decrease
(-16.43%)
View
2021-02-16
4:19 pm
Purchase
13GAddex Therapeutics Ltd
ADXN
CAXTON CORP2,316,293
8.4%
2,316,293increase
(New Position)
View
2021-02-16
4:06 pm
Sale
13GSCYNEXIS, Inc.
SCYX
CAXTON CORP1,474,370
7.5%
-6,461,741decrease
(-81.42%)
View
2021-02-16
3:50 pm
Sale
13GSUNESIS PHARMACEUTICALS INC
SNSS
CAXTON CORP0
0%
-8,134,926decrease
(Position Closed)
View
2021-02-16
3:30 pm
Purchase
13GCardiff Oncology, Inc.
CRDF
CAXTON CORP3,098,447
8.8%
1,140,204increase
(+58.23%)
View
Goto 0, 1, Next